Replies to post #86235 on Biotech Values

[dewophile]

HCV

"Geno-2/3 patients have been harder to cure than geno-1/4 patients for any drug regimen I know of that’s been tried against all of the HCV genotypes."

i think you have that backwards - gen2/3 do better than 1/4, and typically require shorter treatment periods (soc is 24 weeks for gen2/3, and may be even shorter than that depending on viral kinetics)

[dewophile]

idix

"only the nukes offer pan-genotypic coverage"

do you recall if idix's non-nuc and/or PIs also have broader coverage? for some reason i recall they do
tia